{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:32:12Z","timestamp":1788348732998,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"am","delay-in-days":440,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.tmrv.2019.09.007","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T12:09:07Z","timestamp":1571400547000},"page":"225-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction"],"prefix":"10.1016","volume":"33","author":[{"given":"Lubka T.","family":"Roumenina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2019.09.007_bb0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I\u2014molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.tmrv.2019.09.007_bb0010","first-page":"S47","article-title":"Pathogenesis and mechanisms of antibody-mediated hemolysis","volume":"55","author":"Flegel","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fmicb.2019.00663","article-title":"Cloning of the cytochrome b gene from the tomato powdery mildew fungus Leveillula taurica reveals high levels of allelic variation and heteroplasmy for the G143A mutation","volume":"10","author":"Mosquera","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1537-2995.1997.37497265337.x","article-title":"Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells","volume":"37","author":"King","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0030","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0035","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.1300880","article-title":"Antibody polyreactivity in health and disease: statu variabilis","volume":"191","author":"Dimitrov","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0040","doi-asserted-by":"crossref","first-page":"26696","DOI":"10.1074\/jbc.M702751200","article-title":"Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions","volume":"282","author":"Dimitrov","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0045","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1074\/jbc.M114.618124","article-title":"Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity","volume":"290","author":"Lecerf","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-019-0126-7","article-title":"Breaking the law: unconventional strategies for antibody diversification","volume":"19","author":"Kanyavuz","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0055","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ajh.22167","article-title":"Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major","volume":"86","author":"Bao","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0060","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ajh.23488","article-title":"Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease","volume":"88","author":"Bao","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2015-08-663245","article-title":"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease","volume":"127","author":"Vinchi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4049\/jimmunol.1400105","article-title":"Hemin controls T cell polarization in sickle cell alloimmunization","volume":"193","author":"Zhong","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molmed.2016.01.004","article-title":"Heme: modulator of plasma systems in hemolytic diseases","volume":"22","author":"Roumenina","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tracli.2019.02.008","article-title":"Complement activation during intravascular hemolysis: implication for sickle cell disease and hemolytic transfusion reactions","volume":"26","author":"Merle","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0085","first-page":"503","article-title":"Alternative pathway activation in sickle cell disease and beta-thalassemia major","volume":"70","author":"deCiutiis","year":"1978","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0090-1229(85)90139-4","article-title":"Increased activation of the alternative complement pathway in sickle cell disease","volume":"37","author":"Chudwin","year":"1985","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/clin.1994.1072","article-title":"Activation of the alternative complement pathway by red blood cells from patients with sickle cell disease","volume":"71","author":"Chudwin","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0100","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1172\/JCI116706","article-title":"Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients","volume":"92","author":"Wang","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/clin.1995.1131","article-title":"Complement activation during painful crisis in sickle cell anemia","volume":"76","author":"Mold","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0115","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1537-2995.2009.02199.x","article-title":"Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death","volume":"49","author":"Chadebech","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0120","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI59770","article-title":"Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy","volume":"122","author":"Baek","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0125","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3324\/haematol.2018.198622","article-title":"Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule","volume":"104","author":"Lombardi","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0130","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajh.25384","article-title":"Critical role of C5a in sickle cell disease","volume":"94","author":"Vercellotti","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0135","first-page":"56","article-title":"Alternative complement pathway activity in sera from patients with sickle cell disease","volume":"23","author":"Koethe","year":"1976","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2016.04.008","article-title":"The role of complement activation in thrombosis and hemolytic anemias","volume":"54","author":"Chapin","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0145","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.3324\/haematol.2017.174201","article-title":"In vitro evidence of complement activation in patients with sickle cell disease","author":"Gavriilaki","year":"2017","journal-title":"Haematologica. Italy"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fimmu.2018.00179","article-title":"Characterization of renal injury and inflammation in an experimental model of intravascular hemolysis","volume":"9","author":"Merle","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0155","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1073\/pnas.1814797116","article-title":"P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4\/heme-dependent manner","volume":"116","author":"Merle","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.molimm.2019.04.020","article-title":"Anti-inflammatory activity of intravenous immunoglobulin through scavenging of heme","volume":"111","author":"Wiatr","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.03008","article-title":"Heme drives susceptibility of glomerular endothelium to complement overactivation due to inefficient upregulation of heme oxygenase-1","volume":"9","author":"May","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2013-03-489245","article-title":"Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome","volume":"122","author":"Frimat","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0175","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.4049\/jimmunol.179.8.5543","article-title":"Hematin promotes complement alternative pathway-mediated deposition of C3 activation fragments on human erythrocytes: potential implications for the pathogenesis of anemia in malaria","volume":"179","author":"Pawluczkowycz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0180","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","article-title":"Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease","volume":"125","author":"Camus","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0185","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1182\/blood-2012-02-413138","article-title":"Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease","volume":"120","author":"Camus","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium structure and function in kidney health and disease","volume":"15","author":"Jourde-Chiche","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/imr.12479","article-title":"Endothelial cells: source, barrier, and target of defensive mediators","volume":"274","author":"Roumenina","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0200","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1111\/trf.13144","article-title":"Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab","volume":"55","author":"Boonyasampant","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0205","first-page":"1062","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","author":"Dumas","year":"2016","journal-title":"Blood. United States"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0210","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","article-title":"Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease","author":"Chonat","year":"2018","journal-title":"Haematologica. Italy"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0215","first-page":"1","article-title":"Successful outcome of hyperhemolysis in sickle cell disease following multiple lines of treatment: the role of complement inhibition","author":"Vlachaki","year":"2019","journal-title":"Hemoglobin"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrd2369","article-title":"Eculizumab","volume":"6","author":"Parker","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0230","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0235","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0240","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0245","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/trf.12876","article-title":"Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab","volume":"55","author":"Gupta","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0250","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/trf.12882","article-title":"Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion","volume":"55","author":"Weinstock","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.007_bb0255","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/trf.15198","article-title":"Anti-N and anti-Do(a) immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature","volume":"59","author":"Unnikrishnan","year":"2019","journal-title":"Transfusion"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779631930135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779631930135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:18:36Z","timestamp":1760138316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088779631930135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S088779631930135X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.09.007","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}